v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]            
Collaboration revenue         $ 0 $ 80,000
Operating expenses:            
Research and development $ 12,444 $ 12,987 $ 26,528 $ 26,391 56,103 63,386
General and administrative 7,462 6,828 15,564 13,827 28,666 36,448
Impairment of long-lived assets 5,086 0 5,086 0    
Restructuring expenses 4,318 0 4,318 0 0 2,063
Total operating expenses 29,310 19,815 51,496 40,218 84,769 101,897
Loss from operations (29,310) (19,815) (51,496) (40,218) (84,769) (21,897)
Other income, net 3,131 2,519 6,426 5,267 9,889 12,172
Net loss $ (26,179) $ (17,296) $ (45,070) $ (34,951) $ (74,880) $ (9,725)
Net loss per share, Basic $ (0.34) $ (0.28) $ (0.59) $ (0.56) $ (1.18) $ (0.16)
Net loss per share, diluted $ (0.34) $ (0.28) $ (0.59) $ (0.56) $ (1.18) $ (0.16)
Weighted-average common shares outstanding, Diluted 76,264 62,544 76,240 62,506 63,355 61,984
Weighted-average common shares outstanding, Basic 76,264 62,544 76,240 62,506 63,355 61,984
Comprehensive loss:            
Net Income (Loss) $ (26,179) $ (17,296) $ (45,070) $ (34,951) $ (74,880) $ (9,725)
Other comprehensive gain:            
Unrealized gain on marketable securities (54) 12 (741) (48) 44 266
Total other comprehensive gain (54) 12 (741) (48) 44 266
Comprehensive loss $ (26,233) $ (17,284) $ (45,811) $ (34,999) $ (74,836) $ (9,459)